Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
Transplantation Proceedings|January 3, 2006
Prevalence of anemia in renal transplant patients: results from MOST, an observational trialG Fernández Fresnedo, R Palomar, E Rodrigo, et al.
Kidney International Reports|May 5, 2018
Proton Pump Inhibitor Usage and the Risk of Mortality in Hemodialysis PatientsAngel L M de Francisco, Javier Varas, Rosa Ramos, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 22, 2013
A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized studyAdrian Covic, Jutta Passlick-Deetjen, Miroslaw Kroczak, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|May 23, 2014
Strokes in patients on haemodialysis: incidence, onset time and associated factorsLara Belmar, Angel L M de Francisco, Laura Bueno, et al.
Kidney International. Supplement|May 20, 2003
Bone disease in long-term adult kidney transplant patients with normal renal functionCoral Montalban, Angel L M de Francisco, Maria L Mariñoso, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 6, 2021
Oral hydration as a safe prophylactic measure to prevent post-contrast acute kidney injury in oncologic patients with chronic kidney disease (IIIb) referred for contrast-enhanced computed tomography: subanalysis of the oncological group of the NICIR studyCarmen Sebastià, Alfredo Páez-Carpio, Elena Guillen, et al.
Transplantation Proceedings|January 3, 2006
Clinical significance of antiphospholipid antibodies on allograft and patient outcome after kidney transplantationG Fernández-Fresnedo, M López-Hoyos, D San Segundo, et al.
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia|September 27, 2014
Effect of calcium acetate/magnesium carbonate in the treatment of hyperphosphataemia in dialysis patients in real clinical practice. One year follow upAngel L M de Francisco, Lara Belmar, Celestino Piñera, et al.
International Urology and Nephrology|July 2, 2002
Past, present and future of erythropoietin use in the elderlyAngel L M de Francisco, Gema Fernandez Fresnedo, Emilio Rodrigo, et al.
Pageof 9